Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Vascular Smooth muscle Cells
100%
ERK2
100%
Cyclin-dependent Kinase Inhibitor
100%
Allylamine
100%
Collagen Substrate
27%
Basal Level
18%
Control Cell
18%
Substrate-dependent
18%
Cyclin-dependent Kinase Inhibitor p21
18%
Cyclin-dependent Kinase Inhibitor p27
18%
Mitogen-activated Protein Kinase
9%
Rodents
9%
Atherosclerotic Lesions
9%
Collagen
9%
Oxidative Damage
9%
Rat Aorta
9%
Serial Passage
9%
Cycling Cells
9%
Repeated Cycles
9%
Plastic Substrate
9%
Pyrrolidine Dithiocarbamate
9%
PAK1
9%
Vascular Smooth muscle Cell Phenotype
9%
Neuroscience
Vascular Smooth Muscle
100%
Mitogen Activated Protein Kinase 3
100%
Protein Kinase Inhibitor
100%
Cyclin-Dependent Kinase
100%
Cyclin Dependent Kinase Inhibitor 1B
50%
Cyclin Dependent Kinase Inhibitor 1A
50%
P21 Activated Kinase
25%
Pyrrolidines
25%
Medicine and Dentistry
Mitogen Activated Protein Kinase 3
100%
Vascular Smooth Muscle Cell
100%
Cyclin Dependent Kinase Inhibitor
100%
Allylamine
100%
P21
27%
CDKN1B
18%
Cyclin Dependent Kinase Inhibitor 1A
18%
Virus Culture
9%
Pyrrolidine Dithiocarbamate
9%
P21 Activated Kinase
9%
Pharmacology, Toxicology and Pharmaceutical Science
Mitogen Activated Protein Kinase 3
100%
Cyclin Dependent Kinase Inhibitor
100%
Allylamine
100%
Cyclin Dependent Kinase Inhibitor 1B
18%
Cyclin Dependent Kinase Inhibitor 1A
18%
Pyrrolidine Dithiocarbamate
9%
P21 Activated Kinase
9%
Biochemistry, Genetics and Molecular Biology
P21
100%
Cyclin-Dependent Kinase Inhibitor Protein
100%
CDKN1B
40%
extracellular signal regulated kinase
20%
Pyrrolidine Dithiocarbamate
20%
Immunology and Microbiology
Cycline
100%
Vascular Smooth Muscle Cell
100%
Mitogen
25%